COVID-19 UPDATE: All elective surgeries and procedures are cancelled until further notice. Please see our latest visitor policy. If you think you may have been exposed or have symptoms, please call your provider before visiting one of our locations. For more information, please visit our online COVID-19 Information Center or call the Montefiore-Einstein COVID-19 Hotline: 1-844-444-CV19 (1-844-444-2819).

ACTUALIZACIÓN SOBRE EL COVID-19: Todas las cirugías y operaciones quedan canceladas hasta nuevo aviso. Lea nuestras nuevas normas para visitas. Si cree que podría haber estado en contacto con la enfermedad o si presenta síntomas, por favor llame a su proveedor antes de acudir a cualquiera de nuestros centros. Más información en nuestro Centro de Información en Línea sobre el COVID-19 o llamando a la línea informativa Montefiore-Einstein de COVID-19: 1-844-444-CV19 (1-844-444-2819).

Espanol
Transcatheter Aortic Valve Replacement (TAVR)
Home >  Heart (Cardiology & Vascular) >  Services and Treatments >  Transcatheter Aortic Valve Replacement (TAVR)
Print

Services and Treatments

Transcatheter Aortic Valve Replacement (TAVR)

Treating Valvular Heart Disease at Montefiore Medical Center

Montefiore Medical Center is a nationally recognized leader in the diagnosis and treatment of complex valve disease. Here, patients are cared for by a multidisciplinary team composed of highly skilled physicians and surgeons who offer the most advanced interventional and minimally invasive surgical treatments for complex conditions of the heart valves.

Patients diagnosed with aortic stenosis – narrowing of the aortic valve – may experience symptoms including chest pain, lightheadedness, shortness of breath, or rapid heart rate. These patients can often benefit from surgery to replace their ailing valve, but only two-thirds of them undergo the procedure each year. Patients deemed high-risk for traditional open-heart surgery may be eligible for transcatheter aortic valve replacement (TAVR). The TAVR procedure, which is performed via an artery in the groin or via a small incision in the chest, allows the diseased native heart valve to be replaced without open-heart surgery.

Patients with prior aortic valve replacement or mitral valve replacement whose valve is failing may be eligible for catheter-based treatment as an alternative to repeat open surgery. Montefiore now offers replacement using the “valve-in-valve” approach in selected patients.

For more information, or to be scheduled for evaluation by the Montefiore TAVR team, please contact 718-405-8247.

Medtronic Valve

Credit: Edwards Lifesciences LLC, Irvine, CA.